# HBE1

## Overview
The HBE1 gene encodes the hemoglobin subunit epsilon 1, a protein that is part of the hemoglobin family and plays a critical role during embryonic development. This protein is categorized as a globin, which is a type of protein involved in oxygen transport. The epsilon-globin protein is primarily expressed in the embryonic yolk sac and is integral to the formation of embryonic hemoglobin, facilitating oxygen transport in developing red blood cells. The expression of HBE1 is tightly regulated and typically silenced after the embryonic stage, as the body transitions to producing fetal and adult hemoglobin. The regulation involves various transcription factors, including GATA-1, which interact with the gene's regulatory regions to modulate its expression (Hariharan2021Insight; Miccio2010Role). Reactivation of HBE1 has been investigated as a potential therapeutic approach for hemoglobinopathies such as sickle cell disease and β-thalassemia, due to its ability to ameliorate these conditions in model organisms (Park2019EpsilonGlobin).

## Structure
HBE1 (hemoglobin subunit epsilon 1) is a member of the hemoglobin family, primarily expressed during embryonic development. The primary structure of HBE1 consists of a specific sequence of amino acids that are characteristic of the epsilon subunit of hemoglobin. In terms of secondary structure, HBE1 includes alpha helices, which are typical of globin proteins. These helices contribute to the protein's ability to bind oxygen effectively during the early stages of development.

The tertiary structure of HBE1 involves the folding of these alpha helices into a compact, globular form, which is essential for its function as part of the hemoglobin complex. This globular conformation allows HBE1 to interact with other globin subunits, forming a quaternary structure that is crucial for the assembly of embryonic hemoglobin. This assembly is necessary for the proper transport of oxygen in the developing embryo.

Post-translational modifications and splice variants may influence the function and stability of HBE1, although specific details on these modifications are not provided in the context. These modifications could potentially affect the protein's interaction with other subunits and its overall stability within the hemoglobin complex.

## Function
The HBE1 gene encodes the epsilon-globin protein, which is a component of embryonic hemoglobin. During early human development, HBE1 is predominantly expressed in the embryonic yolk sac, where it plays a crucial role in oxygen transport. This expression is part of a tightly regulated sequence of globin gene activation and silencing, known as hemoglobin switching, which ensures the appropriate type of hemoglobin is produced at different developmental stages (Hariharan2021Insight; Miccio2010Role).

In healthy human cells, the expression of HBE1 is typically silenced after the embryonic stage as the body transitions to producing fetal and then adult hemoglobin. The regulation of HBE1 involves various transcription factors, including GATA-1, which can repress its expression by interacting with silencer elements in the gene's regulatory regions (Miccio2010Role). The epsilon-globin protein is part of the hemoglobin complex, facilitating oxygen binding and release in developing red blood cells, which is essential for proper embryonic development (Hariharan2021Insight).

The reactivation of HBE1 has been explored as a potential therapeutic strategy for conditions like sickle cell disease and β-thalassemia, as its expression can ameliorate these conditions in model organisms (Park2019EpsilonGlobin).

## Clinical Significance
Mutations and alterations in the HBE1 gene have been associated with various hemoglobinopathies, including thalassemias. In β-thalassemia/HbE disease, specific single nucleotide polymorphisms (SNPs) in the HBE1 gene, such as rs72872548, have been identified as predictive of disease severity. This SNP is associated with clinical symptoms and influences hemoglobin F (HbF) levels, which are crucial in the pathophysiology of the disease due to the imbalance of globin chains (Munkongdee2021Predictive).

In Pakistani beta-thalassemia major patients, novel variants in the HBE1 gene, such as c.37A>T (p.T13S) and a splice site variant c.92+5G>A, have been identified. These variants might contribute to the thalassemia phenotype, although their specific roles require further research (Ejaz2023Mutational). The c.37A>T variant is considered a polymorphism with a neutral impact on protein function, as predicted by bioinformatics tools (Ejaz2023Mutational).

Overall, the genetic variability in the HBE1 gene and its interactions with other genetic factors play a significant role in the clinical manifestations of hemoglobinopathies, influencing treatment decisions and genetic counseling (Munkongdee2021Predictive).


## References


[1. (Park2019EpsilonGlobin) Sang Yoon Park, Seon-Jin Lee, Hee Jun Cho, Jong-Tae Kim, Hyang Ran Yoon, Kyung Ho Lee, Bo Yeon Kim, Younghee Lee, and Hee Gu Lee. Epsilon-globin hbe1 enhances radiotherapy resistance by down-regulating bcl11a in colorectal cancer cells. Cancers, 11(4):498, April 2019. URL: http://dx.doi.org/10.3390/cancers11040498, doi:10.3390/cancers11040498. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers11040498)

[2. (Ejaz2023Mutational) Samina Ejaz, Iqra Abdullah, Muhammad Usman, Muhammad Arslan Iqbal, Sidra Munawar, Muhammad Irfan Khan, Nagina Imtiaz, Hanniah Tahir, Muhammad Ihsan Bari, Tayyaba Rasool, Aneeza Fatima, Ramsha Anwar, Ayman Durrani, and Yasir Hameed. Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in pakistani beta-thalassemia major patients. Scientific Reports, August 2023. URL: http://dx.doi.org/10.1038/s41598-023-35481-1, doi:10.1038/s41598-023-35481-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-35481-1)

[3. (Munkongdee2021Predictive) Thongperm Munkongdee, Sissades Tongsima, Chumpol Ngamphiw, Pongsakorn Wangkumhang, Chayanon Peerapittayamongkol, Hafizah Binti Hashim, Suthat Fucharoen, and Saovaros Svasti. Predictive snps for β0-thalassemia/hbe disease severity. Scientific Reports, May 2021. URL: http://dx.doi.org/10.1038/s41598-021-89641-2, doi:10.1038/s41598-021-89641-2. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-89641-2)

[4. (Hariharan2021Insight) Priya Hariharan and Anita Nadkarni. Insight of fetal to adult hemoglobin switch: genetic modulators and therapeutic targets. Blood Reviews, 49:100823, September 2021. URL: http://dx.doi.org/10.1016/j.blre.2021.100823, doi:10.1016/j.blre.2021.100823. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.blre.2021.100823)

[5. (Miccio2010Role) Annarita Miccio and Gerd A. Blobel. Role of the gata-1/fog-1/nurd pathway in the expression of human β-like globin genes. Molecular and Cellular Biology, 30(14):3460–3470, July 2010. URL: http://dx.doi.org/10.1128/mcb.00001-10, doi:10.1128/mcb.00001-10. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00001-10)